Takeda Pharmaceutical (TAK) reported fiscal Q1 core earnings Thursday of 154 Japanese yen ($0.94) per share, up from 151 yen a year earlier.
Four analysts polled by FactSet expected 143.97 yen.
Revenue for the quarter ended June 30 was 1.220 trillion, compared with 1.107 trillion yen a year earlier.
Analysts expected 1.150 trillion yen.